Tomas Olsson

Tomas Olsson

Department of Clinical Neuroscience, Karolinska Institutet

Affiliated withKarolinska Institutet

Research Area

Neuroscience

Biography

Tomas Olsson has not added Biography.
If you are Tomas Olsson and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article
Total : 1
Year
Immunohistochemical Analysis in the Rat Central Nervous System and Peripheral Lymph Node Tissue Sections
Publication title
2016

Other Publications

Article
Year
Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.

Journal of neuroimmunology| PubMed ID: 15081258

2004
2004
2004
MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 15294998

2004
2004
2004
Parental age, family size, and risk of multiple sclerosis.

Epidemiology (Cambridge, Mass.)| PubMed ID: 15475721

2004
2005
2005
2005
2005
Genetic dissection of neurodegeneration and CNS inflammation.

Journal of the neurological sciences| PubMed ID: 15894332

2005
2005
2005
2005
2005
2005
Cytokine responses during chronic denervation.

Journal of neuroinflammation| PubMed ID: 16287511

2005
Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis.

The European journal of neuroscience| PubMed ID: 16420447

2006
2006
2006
2006
2006
2006
2006
2006
Genetics of autoimmune neuroinflammation.

Current opinion in immunology| PubMed ID: 16973343

2006
2006
2006
2007
2007
2008
Neurofascin as a novel target for autoantibody-mediated axonal injury.

The Journal of experimental medicine| PubMed ID: 17846150

2007
2008
2008
2008
2008
The genetics of multiple sclerosis and its experimental models.

Current opinion in neurology| PubMed ID: 18451707

2008
2008
2008
2009
2009
2009
2009
TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 19454685

2009
2009
2009
Differential expression, and genetic association, of CD58 in Swedish multiple sclerosis patients.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19497873

2009
2009
2009
Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

The New England journal of medicine| PubMed ID: 19741229

2009
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis.

European journal of human genetics : EJHG| PubMed ID: 19888296

2010
2009
2010
2010
Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 20354066

2010
2009
Management of postpolio syndrome.

The Lancet. Neurology| PubMed ID: 20494327

2010
2010
TNF production in macrophages is genetically determined and regulates inflammatory disease in rats.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 20505148

2010
2010
Confirmation of association between multiple sclerosis and CYP27B1.

European journal of human genetics : EJHG| PubMed ID: 20648053

2010
2010
2010
2010
2010
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 20921238

2011
2010
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 21135023

2011
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 21228027

2011
2011
2011
Principles of a new treatment algorithm in multiple sclerosis.

Expert review of neurotherapeutics| PubMed ID: 21375441

2011
2011
2011
2011
2011
Detecting oxysterols in the human circulation.

Nature immunology| PubMed ID: 21685947

2011
2011
2011
2011
2012
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

The New England journal of medicine| PubMed ID: 21991951

2011
2011
2012
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 22312009

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
Low serum levels of vitamin D in idiopathic inflammatory myopathies.

Annals of the rheumatic diseases| PubMed ID: 22993226

2013
Serum levels of LIGHT in MS.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23037546

2013
2012
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23178691

2013
2013
2013
2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23447359

2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23459571

2013
Changes to anti-JCV antibody levels in a Swedish national MS cohort.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 23463870

2013
2013
2013
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23610432

2013
2013
2013
2013
2013
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.

Molecular & cellular proteomics : MCP| PubMed ID: 23732997

2013
2013
2013
2013
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23924603

2014
2013
2013
2014
Smoking and multiple sclerosis susceptibility.

European journal of epidemiology| PubMed ID: 24146047

2013
Fatty fish intake is associated with decreased occurrence of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 24158977

2014
2013
2013
2014
2014
2014
2014
2014
2014
2014
High-resolution genome screen for bone mineral density in heterogeneous stock rat.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research| PubMed ID: 24643965

2014
2014
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 24659797

2014
2014
2014
2014
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 24821684

2014
Age-dependent effects on the treatment response of natalizumab in MS patients.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 24866201

2015
2014
2014
Neonatal vitamin D status and risk of multiple sclerosis.

Annals of neurology| PubMed ID: 24985080

2014
2014
2015
2014
Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 25112814

2015
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort.

European journal of human genetics : EJHG| PubMed ID: 25159868

2015
2014
2014
2014
2014
2014
2014
β-Amyloid peptides and amyloid plaques in Alzheimer's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics| PubMed ID: 25371168

2015
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 25392339

2015
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 25480867

2015
2015
2015
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

Brain : a journal of neurology| PubMed ID: 25688078

2015
The Role of Environment and Lifestyle in Determining the Risk of Multiple Sclerosis.

Current topics in behavioral neurosciences| PubMed ID: 25707369

2015
2015
2015
2016
2015
2015
2015
2015
PML: The Dark Side of Immunotherapy in Multiple Sclerosis.

Trends in pharmacological sciences| PubMed ID: 26497099

2015
2015
2016
2015
The Expression of BAFF Is Controlled by IRF Transcription Factors.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 26590315

2016
2015
2015
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 26770997

2016
2016
2016
[New techniques can radically change health care].

Lakartidningen| PubMed ID: 26859854

2016
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 26862169

2016
2016
2016
2016
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 27144214

2016
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 27144218

2016
2016
2016
2016
2016
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 27325759

2016
2016
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

Neurology(R) neuroimmunology & neuroinflammation| PubMed ID: 27386506

2016
2016
2016
2016
2016
IL-22 binding protein regulates murine skin inflammation.

Experimental dermatology| PubMed ID: 27676439

2016
Increased basal ganglia binding of (18) F-AV-1451 in patients with progressive supranuclear palsy.

Movement disorders : official journal of the Movement Disorder Society| PubMed ID: 27709757

2016
Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine| PubMed ID: 27765859

2016
2016